🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Research also discovered communities with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of weight loss, glowing reviews and detailed guides for mixing or administering at residence.

After minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these groups, messages show dark colored packages with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her staff has previously seen patients harmed by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious health risks”.